Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
+0.11%
N225
-0.13%
AXJO
-0.36%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
371.19M
Dividend Yield
0.00%
P/E Ratio
-2.66
EPS
-3.06
Revenue
-
Avg. Volume
1.26M

Recently from Cashu

publisher logo
Cashu

Solid Biosciences and Sarepta Enhance Safety in DMD Gene Therapy with Elevidys

2 days ago
publisher logo
Cashu

Solid Biosciences: FDA's New Leadership Aims to Enhance Biologics Regulation and Innovation

about 1 month ago

About

What does SLDB do?
Solid Biosciences, headquartered in Charlestown, Massachusetts, develops gene therapies for Duchenne muscular dystrophy and other cardiac diseases, employing 88 staff since its IPO on January 26, 2018. Their pipeline includes multiple gene therapy candidates and novel platform technologies.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Massachusetts, USA
Website
https://www.solidbio.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
sldb
Solid Biosciences
SLDB
+0.13 (+2.69%)
4.775
USD
At close at Jun 20, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials